King Hussein Cancer Center adopts a number of smoking cessation treatments |
|
Share With Members!
Amman: In an effort to fight the smoking epidemic, and due to the increasing number of smokers in Jordanian that has now reached to 50% males and 18% females, King Hussein Cancer CenterKing Hussein Cancer Center
's Smoking Cessation Clinic, and Pfizer - the world's largest research-based pharmaceutical company are cooperating to conduct the necessary studies to identify the reasons that drive people to smoke and look at individual varieties and conditions, in order to find suitable smoking cessation programs for each individual. However, several international studies have been carried out to reveal a number of smoking cessation therapies and nicotine substitutes, such as: nicotine patches, nicotine gums or lozenges, and nicotine sprays; in addition to non-nicotine prescription medicines like Pfizer's latest breakthrough Champix® (Varenicline) which comes in tablet form and works by blocking nicotine from binding to the receptors in the brain.
On his behalf, Dr. Feras Hawari, Chief, Section of Pulmonary / Adult Care Department, and Director of Smoking Cessation Program at KHCCKHCC said: "It is important to benefit from the efforts put into medical and clinical studies by international pharmaceutical companies; therefore, we need to closely observe all the available smoking cessation therapies in Jordan, and study the efficacy of them locally before recommending the suitable smoking cessation program for each patient."
Tobacco dependence is a chronic, relapsing, physical and psychological condition, and is considered the leading preventable cause of premature death. However, by quitting, smokers improve their chances of surviving lung cancers and heart disease.
By involving a doctor, smokers can now improve their chances of quitting successfully through receiving effective counseling, proper assessment, and the right treatment for the right duration of time.
It is good to note that Jordan has intensified its efforts to ban smoking in public places, as it ranks 10th in the world in terms of laws that prohibit smoking in public places
-Ends-
Quitting Tobacco
Tobacco dependence is a chronic, relapsing, physical and psychological condition which makes quitting both necessary and difficult to achieve. By involving a physician, a smoker improves his or her chance to quit successfully through proper assessment, treatment and support.
About Champix
Champix ® (Varenicline) is the first in a new class of treatment designed to help smokers reach their goal of quitting and staying quit. It is the first non-nicotine therapy specifically designed for smoking cessation by blocking nicotine from binding to the receptors in the brain that make tobacco so addictive.
About Pfizer Inc:
Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health.
© Press Release 2009
Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.
Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Comment on this article 
Loading ...-
Zawya encourages you to add a comment to this discussion. You agree that when you add content to this discussion your comments will not:
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse. - The content posted on www.zawya.com is created by members of the public. The views expressed are theirs and unless specifically stated are not those of Zawya. Zawya reserves the right to review all comments prior to posting and edit or delete any contribution, but Zawya is not responsible for and can not be held liable for any content posted by members of the public on www.zawya.com.
- Zawya is not responsible for the availability or content of any third party sites that are accessible through www.zawya.com. Any links to third party websites from www.zawya.com do not amount to any endorsement of that site by Zawya and any use of that site by you is at your own risk.
- By submitting your comment, you hereby give Zawya the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comments worldwide, in perpetuity.
Loading ...Stories
Companies
| Company Name | Country | Industry |
| Consolidated Contractors Company | Overseas | Construction and Design |
| Zuhair Fayez Partnership Consultants | Saudi Arabia | Construction and Design |
| Saudi Binladin Group | Saudi Arabia | Construction and Design |
| Saudi Electricity Company | Saudi Arabia | Electric Utilities |
| Barwa Real Estate Company | Qatar | Landlords and Developers |
| Roads and Transport Authority - Dubai | UAE | Regulatory and Administrative Bodies |
| Mubadala Development Company | UAE | Investment Firms and Funds |
| Ministry of Health - Saudi Arabia | Saudi Arabia | Ministries and Municipalities |
| Abu Dhabi Oil Refining Company | UAE | Oil |
| Qatar General Electricity and Water Corporation | Qatar | Electric Utilities |
Projects
| Project Name | Country | Sector |
| ENEC - Nuclear Power Plant | UAE | Power and Water |
| Abu Dhabi DOT - Abu Dhabi Metro | UAE | Infrastructure |
| Takreer - Ruwais Refinery Expansion | UAE | Oil and Gas |
| Abu Dhabi Ports Company - Khalifa Port and Industrial Zone (KPIZ) | UAE | Infrastructure |
| Aramco/Dow Chemical - Ras Tanura Integrated Refinery and Petrochemicals Complex | Saudi Arabia | Oil and Gas |
| SATORP - Jubail Refinery and Petrochemical Complex | Saudi Arabia | Oil and Gas |
| Emirates Aluminium (EMAL) - Smelter Complex - Phase 1 | UAE | Industry |
| Dubai Racing Club - Meydan City - Meydan Racecourse | UAE | Real Estate |
| Dubai RTA - Dubai Metro | UAE | Infrastructure |
| IGD - Gasco - Habshan 5 Gas Processing Plant | UAE | Oil and Gas |